Yüklüyor......
hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: A systematic review
High human equilibrative nucleoside transporter 1 (hENT1)-expression has shown a survival benefit in pancreatic cancer patients treated with gemcitabine in several studies. The aim of this systematic review was to summarize the results and try to assess the predictive value of hENT1 for determining...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Baishideng Publishing Group Inc
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4093699/ https://ncbi.nlm.nih.gov/pubmed/25024604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i26.8482 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|